Please wait while we load the requested 10-K report or click the link below:
https://last10k.com/sec-filings/report/1619250/000161925019000007/vlrx10k12312018.htm
SEC Filings
VLRX Annual Reports
VLRX Quarterly Reports
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report November 2018
10-Q Quarterly Report August 2018
10-Q Quarterly Report May 2018
10-Q Quarterly Report November 2017
10-Q Quarterly Report August 2017
10-Q Quarterly Report May 2017
10-Q Quarterly Report November 2019
10-Q Quarterly Report August 2019
10-Q Quarterly Report May 2019
10-Q Quarterly Report November 2018
10-Q Quarterly Report August 2018
10-Q Quarterly Report May 2018
10-Q Quarterly Report November 2017
10-Q Quarterly Report August 2017
10-Q Quarterly Report May 2017
VLRX Corporate News
Financial Exhibit
Listing Status
New Agreement
New Financial Obligation February 2020
Bankruptcy or Receivership
Event for Officers
Financial Exhibit
Financial Obligation Increase
Listing Status
New Agreement
Other Events February 2020
Event for Officers January 2020
Event for Officers December 2019
Earnings Release
Financial Exhibit
Other Events December 2019
Financial Exhibit
Other Events December 2019
Financial Exhibit
Other Events December 2019
Listing Status November 2019
Financial Exhibit
Other Events November 2019
Earnings Release
Financial Exhibit November 2019
Financial Exhibit
Listing Status
New Agreement
New Financial Obligation
Listing Status
New Agreement
New Financial Obligation
February 2020
Bankruptcy or Receivership
Event for Officers
Financial Exhibit
Financial Obligation Increase
Listing Status
New Agreement
Other Events
Event for Officers
Financial Exhibit
Financial Obligation Increase
Listing Status
New Agreement
Other Events
February 2020
Event for Officers
January 2020
Event for Officers
December 2019
Earnings Release
Financial Exhibit
Other Events
Financial Exhibit
Other Events
December 2019
Financial Exhibit
Other Events
Other Events
December 2019
Financial Exhibit
Other Events
Other Events
December 2019
Listing Status
November 2019
Financial Exhibit
Other Events
Other Events
November 2019
Earnings Release
Financial Exhibit
Financial Exhibit
November 2019
Last10K.com | 10-K Annual Report Wed Mar 06 2019
Valeritas Reports Fourth Quarter and Full Year2018 Financial Results
Company Will Host a Conference Call and Webcast Today, March 5, at 4:30 PM ET
BRIDGEWATER, N.J., March 5, 2019 --- Valeritas Holdings, Inc. (NASDAQ: VLRX), a medical technology company and maker of V-Go® Wearable Insulin Delivery device, a simple, all-in-one, wearable insulin delivery option for patients with diabetes, today announced financial results for the three months and full year ended December 31, 2018.
2018 Highlights:
• | Revenues in the fourth quarter grew 19% year-over-year to $6.9 million from $5.8 million in the fourth quarter of 2017 and grew 30% to $26.4 million for the full year ended December 31, 2018 from $20.2 million for the full year 2017. |
• | Gross margin for the fourth quarter was 47.3%, compared to 45.2% in the fourth quarter of 2017, a year-over-year improvement of 210 basis points and 47.1% for the full year 2018 compared to 40.3% for the full year 2017, an improvement of 680 basis points. |
• | Multiple international distribution agreements were signed to bring V-Go to 14 countries and territories. |
• | Additional capital was raised to strengthen the balance sheet and to prepare for U.S. sales force expansion in the first quarter of 2019. |
• | Two significant managed care wins were executed, placing V-Go on formulary in the preferred position at the beginning of 2019. |
"2018 was a successful year for Valeritas, as we accomplished numerous goals including generating higher year-over-year total prescription growth in every quarter and expanding the global footprint for V-Go,” said John Timberlake, President and Chief Executive Officer of Valeritas. "Importantly, additional studies continue to demonstrate that use of V-Go provides significant clinical and economic benefits compared to conventional insulin injection delivery in patients with Type 2 diabetes. With the just completed expansion of our U.S. sales force by twenty-five territories, we look forward to building on our
The following information was filed by Valeritas Holdings Inc. (VLRX) on Wednesday, March 6, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-K Annual Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one year to another to evaluate Valeritas Holdings Inc.'s financial trajectory
Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Valeritas Holdings Inc..
Assess how Valeritas Holdings Inc.'s management team is paid from their Annual Proxy
Valeritas Holdings Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2019 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-K Annual Report
Document And Entity Information
Consolidated Balance Sheets
Consolidated Balance Sheets (Parenthetical)
Consolidated Statements Of Cash Flows
Consolidated Statements Of Cash Flows (Parenthetical)
Consolidated Statements Of Operations
Consolidated Statements Of Stockholders' Equity (Deficit)
Accrued Expense And Other Current Liabilities
Accrued Expense And Other Current Liabilities (Tables)
Accrued Expense And Other Current Liabilities - Schedule Of Accrued Expenses And Other Current Liabilities (Details)
Commitments
Commitments (Tables)
Commitments - Additional Information (Details)
Commitments - Summary Of Minimum Lease Commitments (Details)
Debt
Debt (Tables)
Debt - Additional Information (Details)
Debt - Debt Outstanding (Details)
Employee Benefit Plans
Employee Benefit Plans - Additional Information (Details)
Fair Value Measurements And Fair Value Of Financial Instruments
Income Taxes
Income Taxes (Tables)
Income Taxes - Additional Information (Details)
Income Taxes - Schedule Of Income Tax Expense (Details)
Income Taxes - Significant Deferred Tax Assets And Deferred Tax Liabilities (Details)
Inventory
Inventory (Tables)
Inventory - Additional Information (Details)
Inventory - Schedule Of Inventory (Details)
Liquidity, Uncertainties And Going Concern
Liquidity, Uncertainties And Going Concern - Additional Information (Details)
Nature Of Operations And Organization
Net Loss Per Share
Net Loss Per Share (Tables)
Net Loss Per Share - Additional Information (Detail)
Net Loss Per Share - Schedule Of Antidilutive Options Not Included In Computation Of Weighted Average Common Shares (Detail)
Property And Equipment
Property And Equipment (Tables)
Property And Equipment - Additional Information (Details)
Property And Equipment - Schedule Of Property And Equipment (Details)
Related Party Transactions
Related Party Transactions - Additional Information (Details)
Stockholders' Equity (Deficit)
Stockholders' Equity (Deficit) (Tables)
Stockholders' Equity (Deficit) - Additional Information (Details)
Stockholders' Equity (Deficit) - Schedule Of Stock-Based Compensation Expense (Details)
Stockholders' Equity (Deficit) - Schedule Of Stock Option Activity (Details)
Stockholders' Equity (Deficit) - Schedule Of Time-Based Restricted Stock Awards (Details)
Stockholders' Equity (Deficit) - Schedule Of Weighted Average Assumptions Of Awards Issued (Details)
Subsequent Events
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (Policies)
Summary Of Significant Accounting Policies (Tables)
Summary Of Significant Accounting Policies - Advertising (Details)
Summary Of Significant Accounting Policies - Cash And Cash Equivalents (Details)
Summary Of Significant Accounting Policies - Change In Accounting Principle (Details)
Summary Of Significant Accounting Policies - Geographic Information For Property And Equipment, Net Of Accumulated Depreciation (Details)
Summary Of Significant Accounting Policies - Major Customers And Vendors (Details)
Summary Of Significant Accounting Policies - Recently Issued Accounting Standards (Details)
Summary Of Significant Accounting Policies - Schedule Of Modified Retrospective Method To Adopt New Revenue Guidance (Details) (Details)
Warrants
Warrants (Tables)
Warrants - Additional Information (Details)
Warrants - Schedule Of Activities Of Warrants (Details)
Warrants - Schedule Of Fair Value Of Equity Classified Warrants (Details)
Material Contracts, Statements, Certifications & more
Valeritas Holdings Inc. provided additional information to their SEC Filing as exhibits
Ticker: VLRX
CIK: 1619250
Form Type: 10-K Annual Report
Accession Number: 0001619250-19-000007
Submitted to the SEC: Tue Mar 05 2019 6:01:19 PM EST
Accepted by the SEC: Wed Mar 06 2019
Period: Monday, December 31, 2018
Industry: Surgical And Medical Instruments And Apparatus
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/vlrx/0001619250-19-000007.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...